Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Aug 2024 for Cerevel Therapeutics Holdings, Inc.. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Christopher R. Gordon: trading record in brief
Christopher R. Gordon appears in our data through filings on Cerevel Therapeutics Holdings, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 7 June 2023 to 1 August 2024.
Every open-market trade on record is a purchase: 1 purchase worth €118.4M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.
Most recently, on 5 August 2024, the filings show a transaction in Cerevel Therapeutics Holdings, Inc. The clock since the last published purchase (18 October 2023) now reads 1,097 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher R. Gordon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,282 sharesCommon StockSEC:0000950170-24-090908:0
10,461 sharesCommon StockSEC:0000950170-24-070908:0
5,480,052 shares@ US$22.81100.0% of flowCommon StockSEC:0000899243-23-019970:0
Canonical exit: 14 Jan 2024 (T+90)
3,282 sharesCommon StockSEC:0000899243-23-015226:0
4 of 3 declarations
